With a trading volume of USD 2.7 mn IMRX trades -2.1 percent lower today
Immuneering shares dip 2.1% to $3.71, trailing a 14% monthly decline. Learn why investors watch this biotech’s $241M cap & diagnostic focus.
- IMMUNEERING CORP
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read